Abstract
The ancients (Hippocrates, Seneca) recognized gout as a disease. To consumers it suggests overindulgence, King Henry VIII, obesity, and painful big toes in sedentary old people. To clinicians, it means hyperuricemia, tophi, podagra, monarticular hot joints, and a family history of gout. Gout is all of the above with risks of chronic arthritis and renal failure as well. Well founded treatment protocols are effective for both acute and chronic disease. Incidence rises with age and drug use.1 Controversy lies not in its definition and therapeutic management but in treatment of the asymptomatic state.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wolfe F. Gout and hyperuricemia. Am Fam Physician 1991;43: 2141–50.
Dieppe PA. Investigation and management of gout in the young and the elderly. Ann Rheum Dis 1991;50:263–6.
Reginato AJ, Schumacher HR Jr. Crystal associated arthropathies. Clin Geriatr Med 1988;4:295–322.
McCarthy DJ. Arthritis and allied conditions. 11th ed. Philadelphia: Lea & Febiger, 1989:1645–778.
Mohanaruban K, Joglejer M, Swift CG, Tomlinson K. Significance of single serum urate estimations in acutely hospitalized elderly patients. Age Ageing 1987; 16:221.
Roubenoff R. Gout and hyperuricemia. Rheum Dis Clin North Am 1990;16:539–50.
Sterling LP. The clinical management of gout. Am Pharm 1991; NS31:52–8.
Spector AK, Christman RA. Coexistent gout and rheumatoid arthritis. J Am Podiatr Med Assoc 1989;79:552–8.
Edwards NL. Drugs to lower uric acid levels; how to avoid misuse in gouty arthritis. Postgrad Med 1991;89:111–3.
Levy M, Spino M, Read SE. Colchicine: a state of the art review. Pharmacotherapy 1991;11:196–211.
Roberts WN, Liang MH, Stern SH. Colchicine in acute gout: reassessment of risks and benefits. JAMA 1987;257:1920–2.
Bellamy N, Downie WN, Buchanan WW. Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal antiinflammatory drugs. Br J Clin Pharmacol 1987;24:33–36.
Stuart RA, Gow PJ, Bellamy N, Campbell J, Grigor R. A survey of current prescribing practices of antiinflammatory and urate lowering drugs in gouty arhtritis. NZMJ 1991;104:115–7.
Scopelitis E, McGrath H. NSAID-masked gout. South Med J 1987; 80:1464–5.
Groff GD. Systemic steroid therapy for acute gout: a clinical trial and review of the literature. Semin Arthritis Rheum 1990; 19:329–36.
Axelrod D, Preston S. Comparison of parenteral adrenocorticotro-phic hormone with oral indomethacin in the treatment of acute gout. Arthritis Rheum 1988;31:803–5.
Wallace SL, Singer JZ. Therapy in gout. Rheum Dis Clin North Am 1988;14:441–57.
Fräser RC, Davis RH, Walker FS. Comparative trial of azapropa-zone and indomethacin plus allopurinol in acute gout and hyperuricemia. J R Coll Gen Pract 1987;37:409–11.
Zell SC, Carmichael JM. Evaluation of allopurinol use in patients with gout. Am J Hosp Pharm 1989;46:1813–6.
Gast LF. Withdrawal of long term antihyperuricemic therapy in tophaceous gout. Clin Rheumatol 1987;6:70–3.
Bull PW, Scott JT. Intermittent control of hyperuricemia in the treatment of gout. Adv Exp Med Biol 1989;253A:251–5.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Roth, M.E. (1994). Gout. In: Taylor, R.B. (eds) Family Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-4005-9_114
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4005-9_114
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4757-4007-3
Online ISBN: 978-1-4757-4005-9
eBook Packages: Springer Book Archive